Cancer Treatment Modalities Systemic and Locoregional Approaches: Challenges and Opportunities of Multidisciplinary Approaches

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-030-56267-0_2
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Osimertinib in Untreated EGFR‐Mutated Advanced Non–Small‐Cell Lung Cancer

  2018cited by this paper
• Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal‐Cell Carcinoma

  2018cited by this paper
• Using immunotherapy to boost the abscopal effect

  2018cited by this paper
• Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?

  2018cited by this paper
• Clinical outcomes and costs of robotic surgery in prostate cancer: a multiinstitutional study in Korea

  2018cited by this paper
• Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology

  2018cited by this paper
• Present role and future perspectives of interventional radiology in the treatment of painful bone lesions.

  2018cited by this paper
• Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery: Study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment).

  2018cited by this paper
• Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer

  2018cited by this paper
• Chimeric Antigen Receptor Therapy.

  2018cited by this paper
• Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study.

  2018cited by this paper
• A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis.

  2017cited by this paper
• Nonoperative Management for Invasive Breast Cancer After Neoadjuvant Systemic Therapy: Conceptual Basis and Fundamental International Feasibility Clinical Trials

  2017cited by this paper
• Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance

  2017cited by this paper
• Drug development in the era of precision medicine

  2017cited by this paper
• A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy

  2017cited by this paper
• Long‐Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

  2017cited by this paper
• Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.

  2017cited by this paper
• Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound

  2017cited by this paper
• The discovery of radioactivity

  2017cited by this paper
• Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial.

  2017cited by this paper
• Strategies and challenges for the next generation of antibody–drug conjugates

  2017cited by this paper
• Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.

  2017cited by this paper
• Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Tr

  2017cited by this paper
• The need for multidisciplinarity in specialist training to optimize future patient care

  2017cited by this paper
• The future of cancer treatment: immunomodulation, CARs and combination immunotherapy

  2016cited by this paper
• Pembrolizumab in Relapsed/Refractory Classical Hodgkin Lymphoma: Primary End Point Analysis of the Phase 2 Keynote-087 Study

  2016cited by this paper
• Analysis of mortality in colorectal surgery in the Bi‐National Colorectal Cancer Audit

  2016cited by this paper
• Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.

  2016cited by this paper
• Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway.

  2016cited by this paper
• Systematic review of laparoscopic vs open surgery for colorectal cancer in elderly patients.

  2016cited by this paper
• Criteria for liver transplantation in hepatocellular carcinoma

  2015cited by this paper
• Neoadjuvant chemotherapy for breast cancer increases the rate of breast conservation: results from the National Cancer Database.

  2015cited by this paper
• Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer.

  2015cited by this paper
• Expanding global access to radiotherapy.

  2015cited by this paper
• Cost-Effectiveness of Robotic Surgery for Rectal Cancer Focusing on Short-Term Outcomes

  2015cited by this paper
• Adjuvant therapy for gastric cancer: what have we learned since INT0116?

  2015cited by this paper
• Contemporary trends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States.

  2015cited by this paper
• The evolution of cancer surgery and future perspectives

  2015cited by this paper
• FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.

  2015cited by this paper
• CTLA-4 Blockade Enhances Antitumor Immunity of Intratumoral Injection of Immature Dendritic Cells into Irradiated Tumor in a Mouse Colon Cancer Model

  2014cited by this paper
• Critical Care and Perioperative Monitoring

  2014cited by this paper
• The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?

  2014cited by this paper
• Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer

  2014cited by this paper
• Percutaneous radiofrequency ablation of small renal tumours in patients with a single functioning kidney: long-term results

  2013cited by this paper
• Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma

  2013cited by this paper
• Nivolumab plus ipilimumab in advanced melanoma.

  2013cited by this paper
• Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries.

  2012cited by this paper
• The blockade of immune checkpoints in cancer immunotherapy

  2012cited by this paper
• Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women

  2012cited by this paper
• Adjuvant trastuzumab in HER2-positive breast cancer.

  2011cited by this paper
• Cancer immunotherapy comes of age

  2011cited by this paper
• Improved survival with vemurafenib in melanoma with BRAF V600E mutation.

  2011cited by this paper
• The current landscape of locally advanced rectal cancer

  2011cited by this paper
• Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study.

  2011cited by this paper
• Quality improvement guidelines for percutaneous needle biopsy.

  2010cited by this paper
• F1000 highlights

  2009cited by this paper
• Hospital Stay and Return to Full Activity Following Laparoscopic Colorectal Surgery

  2008cited by this paper
• Biological research in the evolution of cancer surgery: a personal perspective.

  2008cited by this paper
• William Stewart Halsted: his life and contributions to surgery.

  2007cited by this paper
• Multidisciplinary teams in cancer care: are they effective in the UK?

  2006cited by this paper
• Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial.

  2006cited by this paper
• Analysis of Epidermal Growth Factor Receptor Gene Mutation in Patients with Non–Small Cell Lung Cancer and Acquired Resistance to Gefitinib

  2006cited by this paper
• Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

  2004cited by this paper
• Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.

  2003cited by this paper
• Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

  2002cited by this paper
• Charles Theodore Dotter. The father of intervention.

  2001cited by this paper
• Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials

  2000cited by this paper
• Intensity modulated radiation therapy: a clinical review.

  2000cited by this paper
• Neoadjuvant chemotherapy (MVAC) in locally invasive bladder cancer.

  1996cited by this paper
• Mismatch repair deficiency in phenotypically normal human cells

  1995cited by this paper
• Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.

  1993cited by this paper
• Self-expandable prostheses in the tracheobronchial tree.

  1993cited by this paper
• Percutaneous placement of soft, indwelling ureteral stent.

  1985cited by this paper
• The revolution in breast cancer surgery: Science or anecdotalism?

  1985cited by this paper
• Hepatic artery embolization in 120 patients with unresectable hepatoma.

  1983cited by this paper
• Outcome in colorectal carcinoma: seven-year study of a population.

  1980cited by this paper
• Percutaneous transhepatic biliary drainage: technique, results, and applications.

  1980cited by this paper
• Combination chemotherapy as an adjuvant treatment in operable breast cancer.

  1976cited by this paper
• The organ distribution of disseminated 51 Cr-labeled tumor cells.

  1967cited by this paper
• Whole body irradiation; radiobiology or medicine?

  1953cited by this paper
• Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer.

  1949cited by this paper
• NITROGEN MUSTARD THERAPY: Use of Methyl-Bis(Beta-Chloroethyl)amine Hydrochloride and Tris(Beta-Chloroethyl)amine Hydrochloride for Hodgkin's Disease, Lymphosarcoma, Leukemia and Certain Allied and Miscellaneous Disorders

  1946cited by this paper
• ON A NEW KIND OF RAYS.

  1896cited by this paper
• I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894.

  1894cited by this paper
• Contribution To The Knowledge Of Sarcoma

  1891cited by this paper

• Exploration of the cardinal formulation parameters influencing the encapsulation and physicochemical properties of co-loaded anticancer dual drug nanoliposomes

  2022cites this paper
• Fundamentals and applications of metal nanoparticle- enhanced singlet oxygen generation for improved cancer photodynamic therapy

  2022cites this paper